Onyx is now licensed to manufacture commercial API from our UK facility
Since forming in the UK in 2000, our mission has been to deliver high quality chemical and API development and manufacturing services to the pharmaceutical and biotech industries.
In 2011, we became part of the Ipca Laboratories family, which provided access to seven additional API sites globally. Today, we have a pilot plant facility in North Carolina, and in 2021 we added commercial manufacturing capabilities to our UK facility to complement our clinical scale API development and manufacturing services.
